Literature DB >> 3974100

An educational view of a national initiative to lower plasma lipid levels.

W R Harlan, J K Stross.   

Abstract

Two intervention trials have found significant reduction in coronary heart disease mortality and morbidity following reduction of plasma cholesterol levels by diet or drugs. The implications of these studies have been broadened to support a national effort directed to plasma lipid reduction. The evidence suggests that both a public health and medical approach can be effective and that each would be complementary in a national initiative. An important and critical dimension would be education, both of the public and of health professionals. The pertinent educational issues are identified in the categories of knowledge, attitudes, and skills. Economic considerations are an important factor in implementing a national initiative and require attention in development of a program.

Entities:  

Mesh:

Year:  1985        PMID: 3974100

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

1.  Lipid screening in family practice: a critical appraisal of recent evidence.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

2.  Early detection and treatment of hyperlipidemia: physician practices in Canada.

Authors:  T N Tannenbaum; J S Sampalis; R N Battista; E R Rosenberg; L Joseph
Journal:  CMAJ       Date:  1990-11-01       Impact factor: 8.262

3.  Cholesterol reduction in the workplace and in community settings.

Authors:  M G Wilson
Journal:  J Community Health       Date:  1991-02

4.  [Total plasma cholesterol and HDL in a Swiss population: what attitude and norms should be adopted?].

Authors:  B Burnand; D Hausser; M Rickenbach; C Platsoukas; F Gutzwiller
Journal:  Soz Praventivmed       Date:  1988

5.  Detection and treatment of hypercholesterolemia in a biethnic community, 1979-1985.

Authors:  J A Pugh; M P Stern; S M Haffner; H P Hazuda; J Patterson
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.